The past 12 months have not been kind to venture capital. The exuberance of 2014 and 2015 came to an abrupt end early last year when public markets sold off and investors began to question the hefty rounds big streams of outside money permitted. Deal volumes for new investments sank, valuation expectations pulled back and […]
It should be little surprise that public market investors have recently been welcoming of SaaS, or cloud companies. In the almost two decades since the rise of Salesforce.com, they have come to understand the SaaS business model and focus ever closer on its detailed metrics, including the currently in vogue dollar retention rate. They have […]
Funds from Longitude Capital, DCM Ventures and Bay Partners top a portfolio of mid-decade venture funds at the Los Angeles Fire and Police Pension System. The 12-fund portfolio, with vintages of 2004 to 2007, is largely made up of smaller, early stage funds. Half of the funds are under $300 million in size and two […]
In his leisure time, venture capitalist Marlon Nichols enjoys watching and playing sports. But while he’s spent much of April living in Miami near AmericanAirlines Arena, the NBA Miami Heat have hardly been his first priority. He’s the first VC in Residence at Code Fever, a Miami organization that provides entrepreneur training to underserved communities. The group […]
Zymeworks, a Vancouver biotherapeutics provider, has set the terms of its recently filed initial public offering in Canada and the United States. The event marks Canada’s first venture-backed IPO in two years. Zymeworks, backed by multiple VC and strategic investors, plans to raise as much as $110 million (US$82.8 million) from a sale of as many as 5.2 million common shares at US$13 to US$16 per unit, according to the updated prospectus. As a private company, Zymeworks has secured nearly US$150 million from investors, including the US$61.5 million raised in its Series A mezzanine financing last year.
In the battle for the nation’s number two spot for venture capital, Massachusetts has recently been getting the best of New York. In doing so, it has begun to look more like California, at least from a dollars-per-deal perspective. At first, the number two deal-making crown generally belonged to more established Massachusetts. That is until […]
Ever wonder how the value of exits varies year by year, or just how much the dollars GPs shovel into their portfolios ultimately bring back to the industry? Correlation Ventures set out to find the answer and it’s not always as impressive as one might hope. The firm released what it calls the U.S. Venture […]
By Alex Derber, VCJ Correspondent European venture is still to fully recover from the global financial crisis, and some sources suggest that late-stage funding has suffered the most. By the end of 2015, total European VC investment was 40 percent lower than it was in 2008, the trade group Invest Europe says. Venture investment in the […]
Funds from the Column Group, Canaan Partners and GGV Capital lead a portfolio of recently minted venture funds at the University of California. The portfolio is largely made up of mid-sized funds favoring early-stage investing. Seven of the 11 funds range from $306 million to $950 million in size and about half invest in early-stage […]
All the indices were up in March, with venture-backed M&A and IPOs soaring the most. Acquisitions were led by Cisco‘s purchase of the unicorn Appdynamics, the sale of which was announced in January and closed in March. On the IPO front, Snap‘s debut accounted for about 92 percent of the month’s value with its early […]